SMSbiotech Advances COPD Program With FDA IND Clearance
United States, September 17, 2026 SMSbiotech has announced that the U.S. Food and Drug Administration (FDA) has cleared its...
lung disease
Advertisement
Rein Therapeutics Gains FDA Fast Track for LTI-03 in IPF
Austin, Texas, August 20, 2026 Rein Therapeutics announced that the U.S. Food and Drug Administration (FDA) has granted Fast...
Evaxion Advances AI-Designed EVX-05 Brain Cancer Vaccine
Copenhagen, Denmark — August 17, 2026 Evaxion A/S has expanded and refocused its cancer vaccine pipeline with EVX-05, an...
United Therapeutics Completes TETON-PPF Phase 3 Enrollment
Silver Spring, Maryland & Research Triangle Park, North Carolina — August 17, 2026 United Therapeutics Corporation announced the full...
Mereo BioPharma Advances Alvelestat Toward Phase 3 Trial
LONDON, UK; SOLANA BEACH, California; and AHMEDABAD, India, August 11, 2026 Mereo BioPharma Group plc and Sentynl Therapeutics, Inc.,...
Advertisements
Nitinotes Expands U.S. Obesity Trial at Weill Cornell Center
CAESAREA, Israel, August 13, 2026 Nitinotes Ltd., a medical device company developing automated endoluminal suturing technologies for obesity treatment,...
Galvanize Therapeutics Begins Commercial Aliya EX Procedures
Redwood City, California, August,11, 2026 Galvanize Therapeutics, Inc. has announced the completion of the first commercial procedures using its...
aTyr Pharma Prioritizes Efzofitimod as FDA Phase 3 Feedback Approaches
SAN DIEGO, August 7, 2026 aTyr Pharma reported its second quarter 2026 results and announced a corporate restructuring designed...
MiNK Therapeutics to Present AgenT-797 Clinical Update
NEW YORK, August 6, 2026 MiNK Therapeutics announced that it will report its second-quarter 2026 financial results before U.S....
Rein Therapeutics Expands Phase 2 RENEW Trial Across Five Countries
Austin, Texas, USA | July 21, 2026 Rein Therapeutics announced that its Phase 2 RENEW clinical trial evaluating the...
Advertisement
